Overview of the structural basis for transcription regulation by nuclear hormone receptors
- PMID: 15242337
- DOI: 10.1042/bse0400027
Overview of the structural basis for transcription regulation by nuclear hormone receptors
Abstract
The mechanism of action of the nuclear hormone receptors (NHRs) as gene- regulatory molecules has become a major focus of current biological interest. NHRs belong to the superfamily of ligand-activated transcription factors, which are involved in the regulation of homoeostasis, reproduction, development and differentiation. To fully understand their functions, it is important to know the functional three-dimensional structure of these proteins. Molecular cloning and structure-function analyses have revealed that NHRs commonly have three functional regions: the N-terminal, DNA-binding and ligand-binding domains. Structures of some of these domains expressed independently have been solved. However, to date the three-dimensional structure remains unknown for full-length and even for any two domains together of any NHR family member. The available structures nevertheless begin to give clues of how site-specific DNA binding takes place, and how ligand binding alters the ligand-binding domain, consequently affecting potential interactions of the NHRs with co-activators/co-repressors and other components of basal transcriptional machinery. However, precisely how signals from a ligand through its NHR are passed to specific genes is still unknown. Herein, we present a broad overview of current knowledge on the structure and functions of the NHRs.
Similar articles
-
Nuclear hormone receptors in nematodes: evolution and function.Mol Cell Endocrinol. 2011 Mar 1;334(1-2):49-55. doi: 10.1016/j.mce.2010.04.021. Epub 2010 May 10. Mol Cell Endocrinol. 2011. PMID: 20438802 Free PMC article. Review.
-
Intrinsic disorder in nuclear hormone receptors.J Proteome Res. 2008 Oct;7(10):4359-72. doi: 10.1021/pr8003024. Epub 2008 Jul 24. J Proteome Res. 2008. PMID: 18651760 Free PMC article.
-
The structure of the nuclear hormone receptors.Steroids. 1999 May;64(5):310-9. doi: 10.1016/s0039-128x(99)00014-8. Steroids. 1999. PMID: 10406480 Review.
-
Gene repression by nuclear hormone receptors.Essays Biochem. 2004;40:89-104. doi: 10.1042/bse0400089. Essays Biochem. 2004. PMID: 15242341 Review.
-
Transactivation functions of the N-terminal domains of nuclear hormone receptors: protein folding and coactivator interactions.Mol Endocrinol. 2003 Jan;17(1):1-10. doi: 10.1210/me.2002-0258. Mol Endocrinol. 2003. PMID: 12511601 Review.
Cited by
-
Developmental changes of the fetal and neonatal thyroid gland and functional consequences on the cardiovascular system.J Perinatol. 2022 Dec;42(12):1576-1586. doi: 10.1038/s41372-022-01559-3. Epub 2022 Nov 14. J Perinatol. 2022. PMID: 36376450 Review.
-
Role of Phosphorylation in the Modulation of the Glucocorticoid Receptor's Intrinsically Disordered Domain.Biomolecules. 2019 Mar 11;9(3):95. doi: 10.3390/biom9030095. Biomolecules. 2019. PMID: 30862072 Free PMC article. Review.
-
Binding-folding induced regulation of AF1 transactivation domain of the glucocorticoid receptor by a cofactor that binds to its DNA binding domain.PLoS One. 2011;6(10):e25875. doi: 10.1371/journal.pone.0025875. Epub 2011 Oct 7. PLoS One. 2011. PMID: 22003412 Free PMC article.
-
Estrogen receptor-α and estrogen receptor-β in the uterine vascular endothelium during pregnancy: functional implications for regulating uterine blood flow.Semin Reprod Med. 2012 Jan;30(1):46-61. doi: 10.1055/s-0031-1299597. Epub 2012 Jan 23. Semin Reprod Med. 2012. PMID: 22271294 Free PMC article. Review.
-
Nuclear receptors as therapeutic targets in cholestatic liver diseases.Br J Pharmacol. 2009 Jan;156(1):7-27. doi: 10.1111/j.1476-5381.2008.00030.x. Br J Pharmacol. 2009. PMID: 19133988 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources